James H. Coleman is Sr. VP & Business Development at CORTEX PHARMACEUTICALS INC/DE/ (COR). They have made 3 open-market trades across 1 company since 2007, most recently 2008-05-30.
CIK 0001014949
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $35K since 2007, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| COR | 207,587 | $70.7M |
Shares reported on the most recent Form 4, priced at the 2008-06-02 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.